» Articles » PMID: 4175572

A New L-asparaginase with Antitumour Activity?

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 1968 Oct 5
PMID 4175572
Citations 21
Authors
Affiliations
Soon will be listed here.
Citing Articles

Current applications and different approaches for microbial l-asparaginase production.

Cachumba J, Antunes F, Peres G, Brumano L, Santos J, da Silva S Braz J Microbiol. 2016; 47 Suppl 1:77-85.

PMID: 27866936 PMC: 5156506. DOI: 10.1016/j.bjm.2016.10.004.


L-asparaginase in the treatment of patients with acute lymphoblastic leukemia.

Egler R, Ahuja S, Matloub Y J Pharmacol Pharmacother. 2016; 7(2):62-71.

PMID: 27440950 PMC: 4936081. DOI: 10.4103/0976-500X.184769.


The Modified Heparin-Binding L-Asparaginase of Wolinella succinogenes.

Sannikova E, Bulushova N, Cheperegin S, Gubaydullin I, Chestukhina G, Ryabichenko V Mol Biotechnol. 2016; 58(8-9):528-39.

PMID: 27198565 DOI: 10.1007/s12033-016-9950-1.


Studies on Deimmunization of Antileukaemic L-Asparaginase to have Reduced Clinical Immunogenicity--An in silico Approach.

Ramya L, Pulicherla K Pathol Oncol Res. 2015; 21(4):909-20.

PMID: 25740072 DOI: 10.1007/s12253-015-9912-0.


The human asparaginase-like protein 1 hASRGL1 is an Ntn hydrolase with beta-aspartyl peptidase activity.

Cantor J, Stone E, Chantranupong L, Georgiou G Biochemistry. 2009; 48(46):11026-31.

PMID: 19839645 PMC: 2782781. DOI: 10.1021/bi901397h.